A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena
| Date first appeared online | 26/06/2023 |
| DOI | 10.1016/s0140-6736(23)01182-0 |
| Authors | Bain S., Min T. |
| Journal Name | The Lancet |
| Volume | 402 |
| Date first appeared online | 26/06/2023 |
| DOI | 10.1016/s0140-6736(23)01182-0 |
| Authors | Bain S., Min T. |
| Journal Name | The Lancet |
| Volume | 402 |